Found 201 articles for: "chemotherapy"
Pipeline Previews
March 2013 | Volume 12 | Issue 3 | Features | 376 | Copyright © March 2013
Pipeline Previews brings to you information on the newest drugs and medical products as they become available to the dermatologic community. This department may include additional information from th...
Read MoreUse of Lenalidomide in Treating Refractory Prurigo Nodularis
March 2013 | Volume 12 | Issue 3 | Case Reports | 360 | Copyright © March 2013
Prurigo nodularis is a chronic, relapsing neurodermatitis that is often resistant to standard therapies with topical corticosteroids and oral antihistamines. Thalidomide, while efficacious in treating...
Read MoreTopical Formulation Engendered Alteration in p53 and Cyclobutane Pyrimidine Dimer Expression in Chronic Photodamaged Patients
March 2013 | Volume 12 | Issue 3 | Original Article | 336 | Copyright © March 2013
While the clinical attributes of photoaging are well characterized in the literature, the pathogenic mechanisms that underlie these changes are incompletely elucidated. At the molecular level, p53 tum...
Read MoreClinical Case Studies
February 2013 | Volume 12 | Issue 2 | Supplement Individual Articles | 11 | Copyright © February 2013
Resident Rounds. Part III: Neutrophilic Eccrine Hidradenitis in the Setting of Acute Myelogenous Leukemia Treated With Cytarabine
February 2013 | Volume 12 | Issue 2 | Features | 231 | Copyright © February 2013
Chemotherapy-Associated Tongue Hyperpigmentation and Blue Lunula
February 2013 | Volume 12 | Issue 2 | Case Reports | 223 | Copyright © February 2013
Combination chemotherapy is associated with cutaneous and mucosal side effects. Antineoplastic agents have been associated with mucosal and nail pigmentation. We describe a 16-year-old Saudi Arabian g...
Read MoreProgressive Multifocal Leukoencephalopathy and Reversible Progressive Leukoencephalopathy Syndrome in Dermatologic Therapy
February 2013 | Volume 12 | Issue 2 | Original Article | 20 | Copyright © February 2013
Progressive multifocal leukoencephalopathy (PML) is a frequently fatal demyelinating disease of the brain caused by activation of the John Cunningham virus. It typically occurs in immunocompromised pa...
Read MoreCalcipotriene Plus Betamethasone Dipropionate Topical Suspension for the Treatment of Mild to Moderate Psoriasis Vulgaris on the Body: A Randomized, Double-Blind, Vehicle-Controlled Trial
January 2013 | Volume 12 | Issue 1 | Original Article | 92 | Copyright © January 2013
Background/Objectives: A combination topical suspension/gel containing calcipotriene plus betamethasone dipropionate has been developed as a safe and effective treatment for patients with psori...
Read MoreThe Effect of Hand-Foot Skin Reaction Associated With the Multikinase Inhibitors Sorafenib and Sunitinib on Health-Related Quality of Life
November 2012 | Volume 11 | Issue 11 | Original Article | 61 | Copyright © November 2012
Introduction: The multikinase inhibitors sorafenib (SO) and sunitinib (SU) have shown benefit in a wide range of solid tumors. Although these agents are generally well tolerated, the...
Read MoreClinical Trial Review
November 2012 | Volume 11 | Issue 11 | Features | 1382 | Copyright © November 2012
Clinical Trial Review is a JDD department designed to provide physicians with information on drugs and devices undergoin...
Read MoreNews, Views, & Reviews
The Role of RNA Interference in Dermatology: Current Perspectives and Future Directions
November 2012 | Volume 11 | Issue 11 | Features | 1373 | Copyright © November 2012
Clinical Trial Review
October 2012 | Volume 11 | Issue 10 | Features | 1251 | Copyright © October 2012
Clinical Trial Review is a JDD department designed to provide physicians with information on drugs and devices undergoing clinical testing. It is our goal to inform the reader of the status of select ...
Read MoreResident Rounds. Part III: Extramedullary Plasmacytomas Presenting as Asymptomatic Nodules on the Buttocks and Thighs
October 2012 | Volume 11 | Issue 10 | Features | 1244 | Copyright © October 2012
Ingenol Mebutate-Induced Cell Death Patterns in Normal and Cancer Epithelial Cells
October 2012 | Volume 11 | Issue 10 | Original Article | 1181 | Copyright © October 2012
We investigated the proposed necrotic mechanism of ingenol mebutate, a natural compound with anti-cancer properties in human keratinocytes, the human squamous cell carcinoma cell line HSC-5, and HeLa...
Read MoreManagement of Severe Atopic Dermatitis in Children
October 2012 | Volume 11 | Issue 10 | Original Article | 1158 | Copyright © October 2012
Severe childhood atopic dermatitis refers to the presence of recurrent, widespread, eczematous dermatitis that significantly interferes with the daily activities and/or the quality of life of the affe...
Read MoreIngenol Mebutate: Potential for Further Development of Cancer Immunotherapy
October 2012 | Volume 11 | Issue 10 | Original Article | 1156 | Copyright © October 2012
Ingenol mebutate is a diterpene ester derived from the plant Euphorbia peplus and is FDA approved for the topic...
Read MoreLetter: Giant PPD Reaction With Positive Quantiferon-TB Gold in a Patient With Lepromatous Leprosy
October 2012 | Volume 11 | Issue 10 | Editorials | 1151 | Copyright © October 2012
NEWS, VIEWS, & REVIEWS
Radiation Dermatitis: Current Perspectives and Future DirectionsSeptember 2012 | Volume 11 | Issue 9 | Original Article | 1127 | Copyright © September 2012
Griscelli Syndrome Associated With Hemophagocytic Lymphohistiocytosis
September 2012 | Volume 11 | Issue 9 | Original Article | 1126 | Copyright © September 2012
Adverse Cutaneous Reactions to Chemotherapy Agents
September 2012 | Volume 11 | Issue 9 | Original Article | 1120 | Copyright © September 2012